SYS-CON MEDIA Authors: Yeshim Deniz, Doug Masi, Mat Mathews, Newswire, David Smith

News Feed Item

EKO International Corp - NeuroVasc Clinical Inc. marketing update

BURLINGTON, ON, Nov. 15, 2012 /PRNewswire/ - EKO International Corp. (EKNL -Pinksheets) (the 'Company") - is pleased to announce that NeuroVasc Clinical Inc. intends to utilize the services of the iMD distribution engine to instruct health providers in the availability and use of diabetic peripheral neuropathy (DPN) testing units and to inform the health providers of the closest clinics able to provide patients with recommended FREMS treatments.

Information on the value of the iMD services can be obtained on the website  which includes the following quote:

"Award winning iMD® helps physicians, healthcare providers and educators quickly and effectively communicate with patients regarding their health issues directly "At The Point of Care®".

iMD® Health terminals are supplied to physicians, medical specialists, diabetes education centers, chronic disease clinics and healthcare providers across Canada. The iMD Health terminals are connected to a private bidirectional communication system where the physicians have direct access to digital medical content and industry information when they need it."

This service is intended to be of great benefit to patients and to clinics that receive patients referred to them for treatment.

The Company will shortly be providing information on locations, including the WallMart pharmacies, where testing facilities are available for patients suffering from DPN.

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by EKO International ("The Company") are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.


More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.